The impact of liver dysfunction on outcome in patients with multiple injuries

B G Harbrecht1, H R Doyle, K D Clancy

  • 1Department of Surgery, University of Pittsburgh, Pennsylvania, USA.

The American Surgeon
|March 13, 2001
PubMed

Insights

Hepatic dysfunction, indicated by elevated bilirubin, is common in severe trauma patients. This organ dysfunction significantly worsens outcomes, increasing mortality and hospital stay duration.

Area of Science:

  • Trauma Surgery
  • Critical Care Medicine
  • Hepatology

Background:

  • Multiple organ dysfunction syndrome (MODS) is a primary cause of mortality following traumatic injuries.
  • The specific impact of hepatic dysfunction on MODS outcomes in trauma patients remains debated.
  • Clarifying the role of liver dysfunction is crucial for improving patient management.

Purpose of the Study:

  • To investigate the association between hepatic dysfunction and patient outcomes after traumatic injury.
  • To determine if elevated serum bilirubin levels correlate with increased mortality and resource utilization in trauma patients.

Main Methods:

  • Retrospective review of 1962 trauma patients with Injury Severity Score >= 14.
  • Hepatic dysfunction defined as serum bilirubin >= 2.0 mg/dL.
  • Comparison of demographic, injury severity, and outcome data between patients with and without hepatic dysfunction.

Main Results:

  • 154 patients (7.8%) developed hepatic dysfunction.
  • Patients with hepatic dysfunction were older, had higher injury severity scores, and presented with signs of shock (lower blood pressure, base deficit).
  • Hepatic dysfunction was linked to significantly longer intensive care unit and hospital stays, and a higher in-hospital mortality rate (16.2% vs. 2.5%).

Conclusions:

  • Development of hepatic dysfunction in trauma patients reflects injury severity.
  • Hepatic dysfunction is a significant independent predictor of worse outcomes, including increased mortality and prolonged hospitalization.
  • These findings underscore the importance of monitoring liver function in severe trauma patients.

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...